Atlas Phẫu Thuật Thẩm Mỹ (Tập 2) – Atlas of Cosmetic Surgery

Subject Index
563
scars/scarring (Continued)
hair transplantation, 379–380, 381
laser hair removal, 195
management see below
pigmented lesion laser therapy, 173
silicone soft tissue augmentation, 306
scar management, 399–417
dermabrasion see dermabrasion
history, 399–401
preprocedure considerations, 401
scar type dependence, 401
see also atrophic/acne scar management;
keloid/hypertrophic scar management
Scarpa’s fascia, abdominal tumescent liposuction,
344
scar tissue, hair transplantation, 392, 392
sciatic nerve, buttock tumescent liposuction, 347
sclerotherapy, 468–474
adverse effects, 468
agents, 462
Doppler-guided, 474–476, 475
indications, 476
Duplex ultrasound-guided, 474, 475
indications, 476
equipment, 469, 469
foam see foam sclerotherapy
indications, 476
leg telangiectasias, 469, 469–471
sclerosant concentration, 470
leg vein visualization, 470
patient expectations, 468
patient selection, 468–469
perforating veins, 466
postoperative considerations, 472–474
compression, 472–473
compression stockings, 460, 461
injection massage, 473
preoperative considerations, 468–469
reticular veins, 470–472, 471
sclerosant strength, 470, 473
side effects, 468, 475
hyperpigmentation, 473, 475
matting, 473–474, 475
necrosis, 474, 475
small vessel disease, 462
transillumination, 469, 469
treatment intervals, 473
truncal leg vein incompetence, 466
varicose veins, 471, 472
sclerosant concentrations, 473
scopolamine, postoperative nausea and vomiting
(PONV), 86
Sculptra see poly L lactic acid (Sculptra)
sebum, 95
second division maxillary block, nose anesthesia,
72–73
second intention healing, nose reconstruction, 427,
429, 432
sedation
ambulatory phlebectomy, 476
apnea, 81–82
autologous fat transplantation, 415
clinical studies, 78–79
continuum of, 78–79, 79
deep see deep sedation
dermabrasion, 411
sedation (Continued)
emergency equipment, 88
hypoventilation, 81–82
intravenous access, 89
medications, 91
see also specific drugs
moderate see moderate sedation
monitoring, 88
multiple agent use, 89
office-based see office-based sedation
oxygen, 89
patient selection, 88
personnel training, 88
postoperative care, 79
practice guidelines, 88–89
preoperative considerations, 88
recovery care, 89
reversal agents, 89
tumescent liposuction, 327
selective photothermolysis, lasers, 136
self-inflicted injuries, preoperative evaluation, 4–5
serial puncture technique, hyaluronic acid tissue
augmentation, 297–298
seroma, tumescent liposuction, 359, 359
short-stretch compression bandages, 459
side-to-side closure see aesthetic surgical closures
silicone gel sheeting, keloid/hypertrophic scar
management, 406
silicone soft tissue augmentation, 304–306
anesthetics, 304
contraindications, 304
glabella, 305–306
historical aspects, 304
indications, 304
intraocular retinal hemorrhage therapy, 304
lips, 306
microdroplet techniques, 304
nasolabial crease, 305, 305
scars, 306
suture work, 306
SilkTouch laser, atrophic/acne scar management, 413
single lens reflex cameras, photography, 46, 46
skin
anatomy, 117–119
collagens see collagen(s)
elastic fibers, 118–119
face-lift anatomy, 517
fibronectin, 119
glycosaminoglycans, 119
hyaluronic acid, 119
light absorption, 149
natural antioxidants, 117
versican, 118–119
skin aging, 101–102
wrinkled (W) vs. tight (T), 101–102
skin camouflage, 107–115
benefits, 115
clinical studies, 110–111
conditions, 110
see also specific conditions
counseling, 113
history, 107
matching, 113
photographic records, 113
post-laser therapy, 148
postoperative consultations, 113
skin camouflage (Continued)
pretreatment considerations, 113
quality of life, 110
techniques, 114
see also camouflage makeups (CMs)
skin cancer, 23
epidemiology, 26–28
sun beds, 28–29
see also specific types
skin care
Oily–Dry parameters, 96–98, 103
collagens, 97–98
emollients, 97
humectants, 96–97
occlusives, 96
polypeptides, 97–98
photoaging, 96
skin closure, transcutaneous lower eyelid
blepharoplasty, 499, 500
skin diseases, laser hair removal, 190
skin elasticity, neck and jowl tumescent liposuction,
335, 336
skin examination, tumescent liposuction, 326
skin excision, transcutaneous lower eyelid
blepharoplasty, 499
skin flap(s), 420
advancement flaps, 421
ear reconstruction, 431, 438
forehead, 435
glabella, 435, 437
helical, 431
laterally based crescentic, 430
medial canthal defects, 424
perioral, 426–427, 428
staged retroauricular, 431
temple, 440
advantages, 422
arterial flaps, 420
axial flaps, 420
pedicle width, 421
banner-type transposition flaps, 431
bilobed flaps, 430, 436
defect depth effects, 423
ear reconstruction, 431–432
advancement flaps, 431, 438
wedge excisions, 431–432, 438
face-lifts see face-lifts
fasciocutaneous flaps, 420
pedicle width, 421
Hatchet flaps, 430, 435
helical advancement flaps, 431
hinge flaps, 431
keloid/hypertrophic scar management, 404
laterally based crescentic advancement flaps, 430
length limitations, 421
musculocutaneous flaps, 420–421
myocutaneous island pedicle flaps, 420–421
nose reconstruction, 430, 435
nasolabial (melolabial) transposition flaps,
430–431, 437
paramedian forehead flap, 420
pedicle width, 421
posterior platysma suspension, 532, 533
random-pattern flaps, 421
blood supply, 421, 421
see also specific types

564

Subject Index
skin flap(s) (Continued)
rhombic transposition flaps, 430
rotation flaps, 421
alar groove, 429, 433
cheek/chin, 433
nose reconstruction, 430, 435
perioral, 428
vermillion repair, 427, 429
size of, 422–423
staged retroauricular advancement flaps, 431
transposition flaps, 421
banner-type, 431
medial canthal defects, 424, 426
nasolabial (melolabial), 430–431, 437
nose reconstruction, 430
rhombic, 430
temple, 437, 440
vascular perfusion pressure, 421
viability, 423
skin grafts, 420, 421–422
cheek/chin, 433
defect depth effects, 423
full-thickness see full-thickness skin grafts
(FTSGs)
keloid/hypertrophic scar management, 404
nose reconstruction, 427
split-thickness, 421–422
viability, 423
skin hydration, 93–98
aquaporin-3 (AQP-3), 94–95
natural moisturizing factor (NMF), 94
Oily–Dry parameters see skin care
sebum, 95
stratum corneum, 93–94
transepidermal water loss (TEWL), 94
skin laxity, botulinum type A toxin therapy, 280
skin laxity test, tumescent liposuction, 325–326, 326
skin marking
autologous fat transplantation, 312, 312
carbon dioxide laser resurfacing, 234
face-lifts, 520–521, 521
hair transplantation, 383, 384
suture suspension lifts, 507
transcutaneous lower eyelid blepharoplasty, 497
tumescent liposuction see tumescent liposuction
upper eyelid blepharoplasty, 494, 494–495
skin pigmentation, 100–101
ablative skin resurfacing, 233
epidermal lesion laser therapy, 170
hair transplantation, 372
laser hair removal, 190
lasers–tissue interaction, 155–156
nonablative rejuvenation, 199
pigmented (P) vs. nonpigmented (N), 100–101
port-wine stain laser therapy, 143
see also hyperpigmentation; hypopigmentation
skin preparation
glycolic acid treatments, 126
trichloroacetic acid (TCA) chemical peels, 128
skin removal, posterior platysma suspension, 535,
535
skin sensitivity, 98–100
acne skin type, 98–99
comedones, 98
papules, 98
pustules, 98
skin sensitivity (Continued)
allergic skin type, 99–100
rosacea skin type, 99, 99
sensitive (S) vs. resistant (R) skin types, 98–100
stinging skin type, 99, 99
skin suspension, posterior platysma suspension, 532
skin type(s), 93
Bauman Skin Typing System, 102
combinations, 102
dermabrasion, 444
dry (D), 93–95
oily (O), 93–95
Oily–Dry parameters, 96–98
photoaging, 23
pigmented (P) vs. nonpigmented (N), 100–101
sensitive (S) vs. resistant (R) skin types, 98–100
sensitivity-based see skin sensitivity
wrinkled (W) vs. tight (T), 101–102
see also specific types
sleeping position, suture suspension lifts, 513
small pulsed light hair removal systems, 188
small vessel disease see leg vein management
small vessel laser therapy, 462–463, 463
hemoglobin absorbance, 464
spot size, 462, 463
wavelength effects, 463
smart hand use, tumescent liposuction, 333, 334
SMAS (superficial muscular aponeurotic system),
489, 489
aging, 39, 489
face-lifts, 528–531
anatomy, 517–518, 518
malar folds, 489
nasojugal folds, 489
neck and jowl tumescent liposuction, 336
orbitomalar ligament, 489
subcutaneous fat, 489
suborbicularis fat pads (SOOF), 489
SMASectomy, face-lifts, 520, 530–531, 531, 532
SMAS imbrication, face-lifts, 529–530, 530
SMASplication, face-lifts, 520, 528, 528–529, 529
smoking
face-lift patient selection, 519
photoaging, 28
snap test evaluation, neck and jowl tumescent
liposuction, 335
SNARE protein, botulinum type A toxin therapy,
267–268
social expectations, preoperative evaluation, 4
sodium tetradecyl sulfate, sclerotherapy, 462
‘softlight’ technique, laser hair removal, 182
‘soft skin,’ tumescent liposuction, 326
soft tissue augmentation, 287–308
calcium hydroxyapatite (Radiesse), 306–307
collagen see collagen tissue augmentation
history, 287
hyaluronic acids see hyaluronic acid tissue
augmentation
poly L lactic acid see poly L lactic acid
(Sculptra)
products, 288
Sculptra see poly L lactic acid (Sculptra)
silicone see silicone soft tissue augmentation
solar lentigos, pigmented skin type, 100
soybean trypsin inhibitor (STT), pigmentation
inhibition, 100
spider angiomas, laser therapy, 145
millisecond-pulsed 532 nm KTP lasers, 150
pulsed-dye lasers, 149
S-plasty, aesthetic surgical closures, 419–420
split-face comparison
carbon dioxide laser resurfacing, 230
erbium:YAG laser resurfacing, 230
split-thickness skin grafts (STSGs), 421–422
spot size see laser(s)
squamous cell carcinoma (SCC), 26
DNA damage, 25
epidemiology, 26–27
incidence, 27
retinoids, 33
sunscreen use, 27
S-shaped primary closure, cheek/chin aesthetic
surgical closures, 432
staff training, imaging, 53
standard views, photography, 53–54, 54
staphylococcal infections, photodynamic therapy
preoperative considerations, 255
statins, photoaging prevention, 32–33
steatochalasis, definition, 483
stem cells, hair follicles, 180
stem cell therapy, hair transplantation, 372
stepped hairline, posterior platysma suspension,
532, 534
sterility, photography in operating suite, 55
steroids
hyaluronic acid tissue augmentation, 299
keloid/hypertrophic scar management, 404
stinging skin type, 99, 99
storage, botulinum type A toxin therapy, 271
stratum corneum, skin hydration, 93–94
stripping and ligation, truncal leg vein
incompetence, 466–467, 467
studio space, imaging, 53
subcision, atrophic/acne scar management,
409–410, 410, 411
subcutaneous fat
aging-related changes, 39, 310, 310
face-lift anatomy, 517
midfacial SMAS, 489
subcutaneous fat changes, aging, 39
subcutaneous plane, face-lift anatomy, 518
subdermal undermining, tumescent liposuction, 360
submental region, neck and jowl tumescent
liposuction, 336–337, 338
suborbicularis fat pads (SOOF), midfacial SMAS,
489
suborbital aging, 310, 311
suborbital augmentation, autologous fat
transplantation, 315, 315, 316
sub-SMAS plane, face-lift anatomy, 518, 519
sun beds, photoaging, 28–29
sunlight avoidance
dermabrasion, 450
laser surgery, 414
photodynamic therapy, 255, 256, 260
sun protection factor (SPF), sunscreens, 29
sunscreens, 29–30, 31
active ingredients, 29, 29
alpha hydroxy acid treatment, 125–126
laser hair removal, 192
melanoma incidence, 27
squamous cell carcinoma prevention, 27

Subject Index
565
superficial endoscopic perforating surgery,
perforating veins, 465–466
superficial muscular aponeurotic system see SMAS
(superficial muscular aponeurotic system)
superior labial nerve, anatomy, 62
superior lateral orbicularis oculi muscle, botulinum
type A toxin therapy, 276
superior transverse (Withnall’s) ligament, 487
support garments, tumescent liposuction, 358–359
supraorbital nerve, 61
anatomy, 62
local anesthetic techniques, 63
supratrochlear nerve, 61
anatomy, 62
nerve block, 63, 72
surface irregularities, tumescent liposuction, 360
surgical excision, atrophic/acne scar management
see atrophic/acne scar management
surgical expectations, preoperative evaluation, 4
surprise, facial expression, 14
suture bleeding, face-lift complications, 539, 540
suture sensation, suture suspension lifts, 510
suture suspension lifts, 505–516
absorbable sutures, 506
Articulus™ suture, 511
capsule formation, 506
clinical studies, 505–506
complications, 509–511
dimpling, 510
edema, 510
greater auricular nerve neuropathy, 510, 511
linearity, 510
pain, 510
suture sensation, 510
tightening loss, 510
consent form, 514–515
Contour Threads™, 505, 506, 507
durability, 506
equipment, 506–507
history, 505
local anesthesia, 506
postoperative considerations, 509–513
ice packs, 511
patient instructions, 515–516
sleeping position, 513
preoperative considerations, 506–507
patient instructions, 515
procedure, 507, 508, 509, 510, 511
results, 512, 513
skin marking, 507
swelling, hyaluronic acid tissue augmentation, 299
swimming/bathing avoidance, autologous fat
transplantation, 318
syringes, autologous fat transplantation, 313
T
tacrolimus, keloid/hypertrophic scar management,
407
tanning, photoaging, 28–29
tattoos
dermabrasion, 447, 453
laser therapy, 159, 166–168, 167, 171,
173–174
allergic reactions, 167–168
dermabrasion following, 447
tattoos (Continued)
hydrocool dressings, 174, 174
laser-susceptible pigments, 166
multiple wavelength necessity, 166
pigment-dependency, 166, 168
pigment-dependent risks, 168
Q-switched lasers, 166
traumatic tattoos, 168
pigments, absorption spectra, 156, 157
process of, 166
tear trough
blepharoplasty, 484, 485
hyaluronic acid tissue augmentation, 298
transcutaneous lower eyelid blepharoplasty,
499
telangiectasias, 136
laser therapy, 144, 144–146, 145
intense pulsed light (IPL) devices, 144–145
intense pulsed light devices, 144–145
pulsed-dye lasers, 148–149
pulse stacking, 145
Q-switched 532nm potassium titanyl
phosphate (KTP) lasers, 144
leg vein management, 455
nonablative rejuvenation, 200
telephoto lenses, 46–47
telogen, hair follicle growth cycle, 180, 180
telomere length
aging, 101
photoaging, 26
temples
advancement flaps, 440
aesthetic surgical closures see aesthetic surgical
closures
autologous fat transplantation, 314, 315
transposition flaps, 437, 440
‘temporary hair loss,’ laser hair removal, 191
tension minimization, posterior platysma
suspension, 532–533
test spots, laser hair removal, 193
tetracaine, local anesthesia, 60
therapeutic ultrasound, nonablative rejuvenation,
206
thermal confinement, lasers, pigmented skin, 156
thermal damage time (TDT), laser hair removal,
182
thermal relaxation time, lasers, 137–138
thighs, tumescent liposuction see tumescent
liposuction
threading, autologous fat transplantation, 313
three-dimensional conditions, camouflage makeup
limitations, 112, 112
tightening loss, suture suspension lifts, 510
tightening, transcutaneous lower eyelid
blepharoplasty, 499
tissue necrosis, face-lift complications, 541, 542
tissue spatter, pigmented lesion laser therapy, 169
topical anesthesia
ablative skin resurfacing, 233, 234
cocaine, 60
fractional photothermolysis, 235
hyaluronic acid tissue augmentation, hands,
299
plasma skin regeneration (PSR), 237
topical antibiotics, aesthetic surgical closures,
423
topical imiquimod, keloid/hypertrophic scar
management, 407
topical retinoic acid, keloid/hypertrophic scar
management, 407
topical skin care, 93–105
historical aspects, 93
Toradol see ketorolac (Toradol)
total intravenous anesthesia (TIA), 92
clinical studies, 79
tragus
face-lift incision design, 524
posterior platysma suspension, 535–536, 536
transconjunctival lower eyelid blepharoplasty,
496–497, 497
transcutaneous lower eyelid blepharoplasty see
blepharoplasty, lower eyelid
transepidermal water loss (TEWL), skin hydration,
94
transgenic mice, aquaporin-3 (AQP-3), 95
transient diplopia, total second division nerve
block, 66
transillumination, sclerotherapy, 469, 469
transplant repair, hair transplantation see hair
transplantation
traumatic ptosis, definition, 483
traumatic tattoos, laser therapy, 168
treatment intervals, sclerotherapy, 473
tretinoin
dermabrasion, 444
glycolic acid treatments, 126
triamcinolone acetonide, dermabrasion, 447, 454
triangulation see tumescent liposuction
triaxzolam, tumescent liposuction, 331
trichloroacetic acid (TCA) chemical peels,
128–130, 129
adverse effects, 128
with Jessner’s solution, 128
post-dermabrasion, 411
readministration, 128
with retinoic acid, 128
saline compresses, 129
skin preparation, 128
trigeminal nerve, 61
sensory innervation, 61
truncal incompetence see leg vein management
trunk, tumescent liposuction, 342–348
tumescent anesthesia, 73–75, 74
dermabrasion, 444
epinephrine, 74
face-lifts, 75, 522
liposuction, 73
tumescent liposuction, 323–364
abdomen, upper and lower, 342, 342, 343,
344, 345
marking, 344, 344
abdominoplasty with, 326
anatomic sites, 334, 335
see also specific sites
anesthesia, 324
arms, 341
buttocks, 347
delivery of, 331
end-point determination, 332, 332
female breasts, 355–356
gender differences, 332
hips, 345

566

Subject Index
tumescent liposuction (Continued)
incision sites, 331
infiltration fluid amount, 331, 331
infusion rate, 331
knees, 352
male breasts, 357
neck and jowls, 336
path patterns, 331
sensitive areas, 330
solution composition, 330, 331
thighs, inner, 352
types, 331
warming of, 331
see also lidocaine (Xylocaine)
ankles, 354
arms, 341, 341–342
aspirate monitoring, 333, 334
blood loss, 333
body position, 333
buttocks, 346–347, 348
combination with hips/thighs,
347, 348
calves, 354
cannula placement, 335
cannulas, 328, 328, 329, 338
handles, 329
placement, 335
common treatment areas, 325
see also specific areas
consent form, 363–364
cosmetic units, 333
see also specific units
definition, 323
epinephrine, 325, 330
equipment, 328–330
aspirators, 329, 330
cannula handles, 329
cannulas see above
laser-assisted liposuction, 329
powered cannulas, 329, 330
fat replacement, 360
female breasts, 354–356, 356
anesthesia, 355–356
indications, 354
marking, 355, 355
patient selection, 354–355
postoperative packing, 356
ptosis measurement, 355, 355
volume measurement,
355, 355
gender differences, 333
hips, 343, 343, 345, 346, 347
anesthesia, 345
history, 323
hypodermoclysis, 325
imaging, 327
indications, 325
knees, 350–353, 352
anesthesia, 352
irregularities, 350, 352
marking, 352
laser-light liposuction, 334–335
legs, 347–354
patient selection, 348
see also specific areas
liposculpture, 332
tumescent liposuction (Continued)
males, 356–358
abdomen, 357–358, 358
breasts, 356–357
love handles, 357–358, 358
medications to be avoided, 362–363
neck and jowls, 335–340, 337
anesthetic, 336
cannula used, 338
closed neck dissector, 339, 339
danger zones, 338, 338
hyoid bone position, 336–337, 337, 340
marking, 337, 338
patient selection, 335, 336
platysma location, 335
platysma repair, 339–340, 340
postoperative compression, 340
ptotic submandibular glands, 336
rhytides, 335, 336
skin elasticity, 335, 336
snap test evaluation, 335
submental region, 336–337, 338
superficial musculoaponeurotic system
(SMAS), 336
patient expectations, 326
dissatisfaction, 359–360
patient preparation, 327–328
patient selection, 325–326
patient’s wishes, 325
postoperative considerations, 358–360
antibiotics, 327, 359
drainage quantity, 358
incision site drainage, 358
lidocaine toxicity, 359
pain management, 358
support garments, 358–359
preoperative considerations, 326–327
procedures/techniques, 326–360
see also specific anatomical areas
repeats of, 360
room size, 327
safety, 323–324, 326
sedation, 327
side effects, 359–360
seroma, 359, 359
skin laxity test, 325–326, 326
skin marking, 327, 328
female breasts, 355, 355
knees, 352
neck and jowls, 337, 338
thighs, inner, 352
thighs, outer, 349, 350
upper and lower abdomen, 344, 344
waist/mid-lower back, 347
smart hand use, 333, 334
‘soft skin,’ 326
subdermal undermining, 360
thighs, anterior/posterior,
353–354
thighs, inner, 350–353, 352
anesthesia, 352
cannulae, 352–353
Hunter’s canal, 353
irregularities, 350, 352
marking, 352
mid-thigh, 353
tumescent liposuction (Continued)
thighs, outer, 348–350, 349
danger areas, 349–350
endpoint, 350
Gasparotti’s point, 350, 350, 351
marking, 349, 350
pinching end-point, 350, 351
triangulation, 333, 334
trunk, 342–348
waist/mid-lower back, 343, 343, 345–346
marking, 347
type I collagens see collagen(s)
type III collagens see collagen(s)
type IV collagens, 118
type VI collagens, 118
type VII collagens, 118
U
UltraPulse laser, atrophic/acne scar management,
413
ultrasonic liposuction, 324
ultrasound
therapeutic, 206
see also Doppler ultrasound; Duplex ultrasound
ultrasound-guided foam sclerotherapy, 464
ultraviolet (UV) radiation, 24–26
action spectrum, 24–26
altitude, 28
DNA damage, 25
melanoma, 27
ozone layer, 28
penetration, 25
photoaging, 101
UVA, 25
UVB, 25
UVC, 25
ultraviolet protection factor (UPF), clothing/
apparel, 30
upper arm, anterior, tumescent liposuction,
341–342
upper facial muscles, facial expression, 12, 12
upper lid malposition, blepharoplasty
complications, 490
upper lip, botulinum type A toxin therapy, 279
urea, as humectant, 97
UVA, 25
UVB, 25
UVC, 25
‘UV index,’ 32, 32
V
variable pulses, erbium:YAG laser resurfacing, 227,
234
varicose veins
large non truncal, 463–465
sclerotherapy see sclerotherapy
vascular lesions, 135–136, 136
vascular lesions, laser therapy, 135–153
alexandrite lasers, 139, 140, 141
hemangiomas, 146
anesthesia, 147
clinical studies, 139–142
combined (multiple) wavelength lasers, 140,
142

Subject Index
567
vascular lesions, laser therapy (Continued)
diode lasers, 140, 142
epidermal cooling, 138, 138–139
historical aspects, 135–136
intense pulsed light (IPL) devices, 140–141,
141–142, 150–151
port-wine stains (PWS), 143
reactive erythema, 151
telangiectasias, 144–145
laser types, 140–141
millisecond-pulsed 532 nm KTP lasers, 139,
149–150
Nd:YAG lasers, 140, 142
hemangiomas, 146
port-wine stains (PWS), 143
preoperative considerations, 147
pulsed-dye lasers, 139, 140, 147–149
hemangiomas, 146, 149
port-wine stains, 147–148
spider angiomas, 149
telangiectasias, 148–149
Q-switched 532nm potassium titanyl
phosphate (KTP) lasers, 139, 140
telangiectasia, 144
telangiectasias, 144
safety precautions, 147
see also specific lesions
vascular perfusion pressure, skin flaps, 421
vasoconstrictor effects, cocaine, 60
Veil Cover Cream, camouflage makeup, 110
venous system, legs, 455–456, 456, 457
see also leg vein management; specific veins
verapamil, keloid/hypertrophic scar management,
407
vermillion border
perioral aesthetic surgical closures,
426, 427
repair, rotation flaps, 427, 429
Versed see midazolam (Versed)
versican, in skin, 118–119
vertex (V) area, hair transplantation, 384
vertical mattress sutures, aesthetic surgical closures,
422, 423
vertical rhytides
aging, 39
botulinum type A toxin therapy,
279
vesiculation, nonsurgical skin tightening side effects,
222
videography, 50–52, 52
audio recording, 52
equipment selection, 51–52
lighting, 52
line of view, 51
viral infections
hair transplantation, 377
see also specific viral infections
visible light devices, nonablative rejuvenation, 202,
202–203
vision loss, blepharoplasty complications, 490
Vistaril (hydroxyzine hydrochloride), tumescent
liposuction, 331
vitamin D
photoaging prevention, 33
synthesis, 32
vitiligo, skin camouflage, 107, 108
volume measurement, female breast tumescent
liposuction, 355, 355
volume restoration, 43
hyaluronic acid lip augmentation, 296–297,
297
W
waist, tumescent liposuction see tumescent
liposuction
washing, post-hair transplantation, 393
wavelength, lasers, 136–137
webbing, blepharoplasty complications,
491
wedge excisions, ear reconstruction, 431–432,
438
wheals, hyperhidrosis botulinum type A toxin
therapy, 280
white balance, photography, 48–49, 49
wide-angle lenses, 46
wound care
ablative skin resurfacing, 237–238
aesthetic surgical closures, 423–424
blepharoplasty, 501
wound closure tension control, hair transplantation,
380
wound contraction, cheek/chin aesthetic surgical
closures, 433
wound healing, dermis, 120–121
wound infection, aesthetic surgical closures, 423
wrinkles
bipolar radiofrequency/diode laser therapy, 215
nonablative rejuvenation, 205
prevention, 103
X
xeroderma pigmentosum, DNA damage, 25
xerosis, 94
Xylocaine see lidocaine (Xylocaine)
Z
zoom lenses, 47, 47
Zyderm, 300
zygoma, calcium hydroxyapatite (Radiesse) soft
tissue augmentation, 307
zygomatic arch
collagen tissue augmentation, 301–302
hyaluronic acid tissue augmentation see
hyaluronic acid tissue augmentation
poly L lactic acid (Sculptra), 303
zygomatic nerve, anatomy, 62
zygomaticofacial nerve
anatomy, 62
local anesthetic block, 63–64, 65, 66
zygomaticotemporal nerve
anatomy, 62
local anesthetic block, 63–64, 65
anesthetized area, 66
scalp, 70
zygomaticus major, emotion/expression
connection, 16